What is Achieve Life Sciences's change in other assets?

Achieve Life Sciences (ACHV) reported change in other assets of -$507K in Q2 2025.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

PfizerPFE

-$322.25M+61.9%

Sionna Therapeutics, Inc. Common StockSION

-$740K-232%

Net income-$10.2M+20.7%

EPS (diluted)-$0.19+48.6%

Cash & equivalents$28.1M+116%

Total debt$5.6M+332%

Total equity$10.7M+3.9%

Total assets$33.1M+21.0%

Operating cash flow-$6.9M+37.5%

CapEx$750.0—

Free cash flow-$12.4M—

Market cap$585.16M+404%

Enterprise value$562.71M+439%

Return on equity-496.1%-906pp

Debt / equity0.5×+0.4×

Current ratio2.6×-0.9×

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Achieve Life Sciences’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Achieve Life Sciences's change in other assets?: Achieve Life Sciences (ACHV) reported change in other assets of -$507K in Q2 2025.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.